Longitudinal inter‐ and intra‐individual human brain metabolic quantification over 3 years with proton MR spectroscopy at 3 T

The longitudinal repeatability of proton MR spectroscopy (1H‐MRS) in the healthy human brain at high fields over long periods is not established. Therefore, we assessed the inter‐ and intra‐subject repeatability of 1H‐MRS in an approach suited for diffuse pathologies in 10 individuals, at 3T, annually for 3 years. Spectra from 480 voxels over 360 cm3 (∼30%) of the brain, were individually phased, frequency‐aligned, and summed into one average spectrum. This dramatically increases metabolites' signal‐to‐noise‐ratios while maintaining narrow linewidths that improve quantification precision. The resulting concentrations of the N‐acetylaspartate, creatine, choline, and myo‐inositol are: 8.9 ± 0.8, 5.9 ± 0.6, 1.4 ± 0.1, and 4.5 ± 0.5 mM (mean ± standard‐deviation). the inter‐subject coefficients of variation are 8.7%, 10.2%, 10.7%, and 11.8%; and the longitudinal (intra‐subject) coefficients of variation are lower still: 6.6%, 6.8%, 6.8%, and 10%, much better than the 35%, 44%, 55%, and 62% intra‐voxel coefficients of variation. The biological and nonbiological components of the summed spectra coefficients of variation had similar contributions to the overall variance. Magn Reson Med, 2011. © 2011 Wiley‐Liss, Inc.

[1]  Arend Heerschap,et al.  Short echo time 1H MRSI of the human brain at 3T with adiabatic slice‐selective refocusing pulses; reproducibility and variance in a dual center setting , 2010, Journal of magnetic resonance imaging : JMRI.

[2]  W M Brooks,et al.  Reproducibility of 1H‐MRS in vivo , 1999, Magnetic resonance in medicine.

[3]  David H. Miller,et al.  Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis , 2004, NeuroRX.

[4]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[5]  David H. Miller,et al.  Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[6]  B. Mueller,et al.  Proton echo‐planar spectroscopic imaging of J‐coupled resonances in human brain at 3 and 4 Tesla , 2007, Magnetic resonance in medicine.

[7]  V. Calhoun,et al.  Test‐retest reliability and reproducibility of short‐echo‐time spectroscopic imaging of human brain at 3T , 2011, Magnetic resonance in medicine.

[8]  Robert E. Lenkinski,et al.  Recent advances in magnetic resonance neurospectroscopy , 2007, Neurotherapeutics.

[9]  Gadi Goelman,et al.  Optimizing the efficiency of high‐field multivoxel spectroscopic imaging by multiplexing in space and time , 2006, Magnetic resonance in medicine.

[10]  Oded Gonen,et al.  Reproducibility of 3D proton spectroscopy in the human brain , 2002, Magnetic resonance in medicine.

[11]  Daniel J Blezek,et al.  Automatic repositioning of single voxels in longitudinal 1H MRS studies , 2005, NMR in biomedicine.

[12]  P M Matthews,et al.  Guidelines for using proton MR spectroscopy in multicenter clinical MS studies , 2007, Neurology.

[13]  Harald Hampel,et al.  A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobe , 2006, European Radiology.

[14]  H. Rusinek,et al.  MR spectroscopy indicates diffuse multiple sclerosis activity during remission , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  A. A. Maudsley,et al.  Reproducibility of serial whole‐brain MR Spectroscopic Imaging , 2009, NMR in biomedicine.

[16]  Oded Gonen,et al.  Diffusely elevated cerebral choline and creatine in relapsing‐remitting multiple sclerosis , 2003, Magnetic resonance in medicine.

[17]  Oded Gonen,et al.  Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T , 2008, Magnetic resonance in medicine.

[18]  O. Gonen,et al.  SNR versus resolution in 3D 1H MRS of the human brain at high magnetic fields , 2001, Magnetic resonance in medicine.

[19]  Saadallah Ramadan,et al.  Neurospectroscopy: the past, present and future. , 2010, Chemical reviews.

[20]  V. Govindaraju,et al.  Automated spectral analysis III: Application to in Vivo proton MR Spectroscopy and spectroscopic imaging , 1998, Magnetic resonance in medicine.

[21]  P. Barker Clinical MR Neuroimaging: Fundamentals of MR spectroscopy , 2004 .

[22]  Jürgen Gieseke,et al.  1H metabolite relaxation times at 3.0 tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation , 2004, Journal of magnetic resonance imaging : JMRI.

[23]  Chris Boesch,et al.  Integrated data acquisition and processing to determine metabolite contents, relaxation times, and macromolecule baseline in single examinations of individual subjects , 2005, Magnetic resonance in medicine.

[24]  Regula S Briellmann,et al.  Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T. , 2005, AJNR. American journal of neuroradiology.